Security key
68277Q105
OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)
CUSIP: 68277Q105
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Class A Common Stock, par value $0.0001 per share
- Total 13F shares
- 10,219,418
- Total 13F value
- $28,103,553
- Share change
- -559,478
- SEC-reported price per share
- $2.75
- Number of holders
- 41
- Value change
- -$1,295,979
- Number of buys
- 15
- Number of sells
- 20
- Shares outstanding
- 40,281,283
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q3 2025
Institutions
41
Top holders
10
OKUR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
OnKure Therapeutics, Inc. SEC filings
OnKure Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68277Q105
Recent filing periods:
Ownership snapshot
Top reported holders of OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ACORN BIOVENTURES, L.P.
Disclosed value leader
ACORN BIOVENTURES, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2025
3/4/5
13D/G
13F
Lead comparable stake: 22%
13D/G row: ACORN BIOVENTURES, L.P.
Showing 1-6 of 15 holder rows.
Quick read
ACORN BIOVENTURES, L.P. leads the comparable SEC ownership view at 22%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ACORN BIOVENTURES, L.P.
22%
Shay Capital LLC
6.3%
CANTOR FITZGERALD & CO.
5.2%
Deep Track Capital, LP
4.1%
Invest A/s Lundbeckfond
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. |
3/4/5
13D/G
10%+ Owner · Anders Hove
|
22%
from 13D/G
|
$9,098,765
4,279,348 shares
mixed-class rows
|
— | 15 May 2025 |
| Shay Capital LLC |
13D/G
13F
Company
|
6.3%
|
$2,057,944
810,214 shares
|
$0 | 15 May 2025 |
| CANTOR FITZGERALD & CO. |
13D/G
Cantor Fitzgerald Securities
|
5.2%
|
$1,606,894
669,539 shares
|
$0 | 30 Jun 2025 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
4.1%
|
$1,330,932
523,989 shares
|
$0 | 31 Dec 2024 |
| Invest A/s Lundbeckfond |
13D/G
Lundbeckfond Invest A/S
|
1.6%
|
$515,930
203,122 shares
|
$0 | 31 Dec 2024 |
| RiverVest Venture Fund III, L.P. |
13D/G
John P. McKearn, Ph.D.
|
1.6%
|
$333,517
196,198 shares
|
$0 | 16 Jan 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
41
Shares
10,219,418
Rows available
41
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
48
Q3 2025 holders
41
Holder diff
-7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend